Provider of diversified pharmaceutical products and medicines for livestock animals
Annual revenue - Latest available
Total funding - Funding intelligence
Employees 105 Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Lah.de

Lah.de is a company based in Germany was acquired by Elanco in February 2014. The company has 105 employees as of December 31, 2021. Lah.de operates in a competitive market with competitors including Zoetis, Ceva, Bio-Sourcing, Phage Lab and Proteon Pharmaceuticals, among others.

  • Headquarter Germany
  • Employees 105 as on 31 Dec, 2021
  • Sectors
    Agriculture
  • Phone
    Locked
  • Website
    Locked
  • Legal Name Elanco Deutschland Gmbh
Operational Areas
Agriculture → Livestock & Animal Nutrition Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    105

    as on Dec 31, 2021

  • Acquired by
    Elanco

    (Feb 24, 2014)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Lah.de

Premium access

Detailed funding history for Lah.de

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Lah.de

Lah.de has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Elanco.

All
Institutional
Investor Description Founded Year Domain Location
Veterinary food and medicines products are provided for animal health.
Locked Locked Locked
Premium access

Investor details for Lah.de

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Lah.de

Investments
Premium access

Investment portfolio details for Lah.de

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Lah.de

Premium access

Detailed financials for Lah.de

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Lah.De Comparisons

Lah.de Primary company
Description
Provider of diversified pharmaceutical products and medicine...
Location
Germany
Founded Year
-
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
105
As of 2021
Premium access

Peer comparison for Lah.de

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Lah.de

Lah.de operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zoetis, Ceva, Bio-Sourcing, Phage Lab and Proteon Pharmaceuticals, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Animal medicines, vaccines, and diagnostics are manufactured and supplied.
Locked Locked Locked
Animal health therapeutics are developed and supplied globally by Ceva.
Locked Locked Locked
Biopharmaceuticals for animals are manufactured and supplied through partnerships.
Locked Locked Locked
Bacteriophage treatments for animal infections are developed by the company.
Locked Locked Locked
Therapeutics for animal infectious diseases are developed via phage platforms.
Locked Locked Locked
Proprietary monoclonal antibody platform is provided for pig intestinal infections.
Premium access

Detailed competitors of Lah.de

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Lah.De

Premium access

Complete news archive for Lah.de

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lah.de

Lah.de is headquartered in Germany.

As of Dec 31, 2021, the latest employee count at Lah.de is 105.

Provider of diversified pharmaceutical products and medicines for livestock animals. It offers products for livestock, cattle, pigs and poultry. It also offers antiparasitics for pets and provides services for pet and livestock through its online platform.

Lah.de's top competitors include Zoetis, Ceva and Bio-Sourcing.

Lah.de has 1 investor. Key investors include Elanco.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available